Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study

Small Cell Lung ◽

1422 POSTER Observational Cohort Study of Plasma Levels of Biomarkers in Patients With Non-small Cell Lung Cancer Treated With Bevacizumab

European Journal of Cancer ◽

10.1016/s0959-8049(11)70915-7 ◽

2011 ◽

Vol 47 ◽

pp. S176

Author(s):

L. Iqlesias ◽

A. Rodriguez-Garzotto ◽

M.T. Agullo-Ortufio ◽

S. Ponce ◽

V. Diaz-Garcia ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Plasma Levels ◽

Small Cell ◽

Small Cell Lung ◽

Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.3948 ◽

2016 ◽

Vol 25 (5) ◽

pp. 569-577 ◽

Cited By ~ 1

Author(s):

Larry Leon ◽

Michael Kosty ◽

Mohammad Jahanzeb ◽

David Spigel ◽

Antoinette J. Wozniak ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Disease Progression ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Clinical outcomes (CO) for special populations of patients (pts) with advanced non-small cell lung cancer (NSCLC): Results from ARIES, a bevacizumab (BV) observational cohort study (OCS).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7618 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7618-7618 ◽

Cited By ~ 15

Author(s):

A. J. Wozniak ◽

J. Garst ◽

M. Jahanzeb ◽

M. P. Kosty ◽

R. Vidaver ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Small Cell ◽

Special Populations ◽

Small Cell Lung ◽

9020 POSTER DISCUSSION Use of Bevacizumab (BV) After Induction Therapy is Associated With Survival Benefit in Patients (pts) With Non-small Cell Lung Cancer (NSCLC) in the ARIES Observational Cohort Study (OCS)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72332-2 ◽

2011 ◽

Vol 47 ◽

pp. S598 ◽

Cited By ~ 2

Author(s):

M.P. Kostv ◽

J.R. Brahmer ◽

M. Jahanzeb ◽

P. Kumar ◽

R. Robles ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Induction Therapy ◽

Cell Lung Cancer ◽

Survival Benefit ◽

Small Cell ◽

Small Cell Lung ◽

9073 POSTER Clinical Outcomes for Bevacizumab (BV)-treated Elderly Patients With Non-small Cell Lung Cancer (NSCLC) – Results From the ARIES Observational Cohort Study (OCS)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72385-1 ◽

2011 ◽

Vol 47 ◽

pp. S614

Author(s):

A. Wozniak ◽

M.R. Kosty ◽

M. Jahanzeb ◽

J. Garst ◽

D. Spigel ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study

Targeted Oncology ◽

10.1007/s11523-014-0355-4 ◽

2015 ◽

Vol 10 (4) ◽

pp. 509-516 ◽

Cited By ~ 3

Author(s):

Michael P. Kosty ◽

Antoinette J. Wozniak ◽

Mohammad Jahanzeb ◽

Larry Leon ◽

Susan Fish ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Induction Phase ◽

Small Cell Lung ◽

Bevacizumab Treatment ◽

Baseline (BL) radiographic characteristics and severe pulmonary hemorrhage (SPH) in bevacizumab (BV)-treated non-small cell lung cancer (NSCLC) patients (pt): Results from ARIES, an observational cohort study (OCS).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7619 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7619-7619 ◽

Cited By ~ 5

Author(s):

P. Kumar ◽

N. A. Fischbach ◽

J. R. Brahmer ◽

D. R. Spigel ◽

S. Beatty ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Pulmonary Hemorrhage ◽

Small Cell ◽

Small Cell Lung ◽

Observational Cohort ◽

Nsclc Patients

Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?

PLoS ONE ◽

10.1371/journal.pone.0232669 ◽

2020 ◽

Vol 15 (5) ◽

pp. e0232669

Author(s):

Nahila Justo ◽

Jonas Nilsson ◽

Beata Korytowsky ◽

Johan Dalen ◽

Terri Madison ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Retrospective Observational Cohort Study

Small Cell Lung ◽

Single Population ◽

Observational Cohort ◽

9006 Safety of bevacizumab (BV) combined with chemotherapy (CTX) in patients (pts) with non-small cell lung cancer (NSCLC): interim results from the ARIES Lung observational cohort study (OCS)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71719-7 ◽

2009 ◽

Vol 7 (2) ◽

pp. 507 ◽

Cited By ~ 2

Author(s):

M. Jahanzeb ◽

N. Fischbach ◽

M. Kosty ◽

P. Kumar ◽

D. Spigel ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Outcomes in Elderly Patients with Advanced Non-small Cell Lung Cancer: Results from ARIES, a Bevacizumab Observational Cohort Study

Clinical Oncology ◽

10.1016/j.clon.2014.12.002 ◽

2015 ◽

Vol 27 (4) ◽

pp. 187-196 ◽

Cited By ~ 11

Author(s):

A.J. Wozniak ◽

M.P. Kosty ◽

M. Jahanzeb ◽

J.R. Brahmer ◽

D.R. Spigel ◽

...

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽